BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28705587)

  • 1. Diagnosis of Parkinson's disease and the level of oxidized DJ-1 protein.
    Yamagishi Y; Saigoh K; Saito Y; Ogawa I; Mitsui Y; Hamada Y; Samukawa M; Suzuki H; Kuwahara M; Hirano M; Noguchi N; Kusunoki S
    Neurosci Res; 2018 Mar; 128():58-62. PubMed ID: 28705587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for Parkinson's disease].
    Ogawa I; Saito Y; Saigoh K; Hosoi Y; Mitsui Y; Noguchi N; Kusunoki S
    Brain Nerve; 2014 Apr; 66(4):471-7. PubMed ID: 24748095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DJ-1 as a Biomarker of Parkinson's Disease.
    Saito Y
    Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
    Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson's disease patients.
    Saito Y; Akazawa-Ogawa Y; Matsumura A; Saigoh K; Itoh S; Sutou K; Kobayashi M; Mita Y; Shichiri M; Hisahara S; Hara Y; Fujimura H; Takamatsu H; Hagihara Y; Yoshida Y; Hamakubo T; Kusunoki S; Shimohama S; Noguchi N
    Sci Rep; 2016 Jul; 6():30793. PubMed ID: 27470541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.
    Herbert MK; Eeftens JM; Aerts MB; Esselink RA; Bloem BR; Kuiperij HB; Verbeek MM
    Parkinsonism Relat Disord; 2014 Jan; 20(1):112-5. PubMed ID: 24075122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.
    Watanabe Y; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Uchiyama T; Kadowaki T; Matsubara T; Hirata K
    Intern Med; 2017 Nov; 56(21):2871-2878. PubMed ID: 28943542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients.
    Saito Y; Hamakubo T; Yoshida Y; Ogawa Y; Hara Y; Fujimura H; Imai Y; Iwanari H; Mochizuki Y; Shichiri M; Nishio K; Kinumi T; Noguchi N; Kodama T; Niki E
    Neurosci Lett; 2009 Nov; 465(1):1-5. PubMed ID: 19733211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
    Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
    Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy.
    Murakami N; Sako W; Haji S; Furukawa T; Otomi Y; Otsuka H; Izumi Y; Harada M; Kaji R
    J Neurol Sci; 2020 Feb; 409():116627. PubMed ID: 31865188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    Mov Disord; 2014 Nov; 29(13):1599-605. PubMed ID: 25258345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of blink reflex in multisystem atrophy, progressive supranuclear palsy and Parkinson disease.
    Szmidt-Salkowska E; Gawel M; Jamrozik Z; Salkowska-Wanat J; Gawel D; Kaminska A
    Neurol Neurochir Pol; 2016; 50(5):336-41. PubMed ID: 27591058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases.
    Ohmichi T; Mitsuhashi M; Tatebe H; Kasai T; Ali El-Agnaf OM; Tokuda T
    Parkinsonism Relat Disord; 2019 Apr; 61():82-87. PubMed ID: 30502924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Bukhatwa S; Zeng BY; Rose S; Jenner P
    Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.